Research Article

The utility of ETCO2 value in predicting the progress of the disease and mortality risk in hospitalized patients with COVID-19 pneumonia

Volume: 3 Number: 4 December 26, 2022
EN TR

The utility of ETCO2 value in predicting the progress of the disease and mortality risk in hospitalized patients with COVID-19 pneumonia

Abstract

Aim: End-tidal CO2 (ETCO2) levels are reflective of the ventilatory and metabolic/perfusion status of a patient, regardless of his/her SpO2 values. This study aimed to investigate the utility of ETCO2values in predicting the need for intubation, ICU admission, and mortality in hospitalized patients with COVID-19 pneumonia. Material and Method: A total of 108 hospitalized patients with COVID-19 pneumonia were included. Data on respiratory parameters (oxygen saturation, ETCO2, and respiratory rate [RR]- with and without O2 [w/wo O2]) and laboratory parameters were recorded. Results: The need forintensive care unit(ICU) admission was associated with significantly higher ETCO2 values (wO2:27.9 (4.6) vs. 18.6(8.4), p=0.040; woO2: 30.1(4.9) vs. 23.8(6.9), p=0.040). Mortality was associated with higher likelihood of higher RR (wO2:32.4(5.8) vs. 24.6(6.8), p=0.002) and lower oxygen saturation (wO2:92.9(3.8) vs. 95.5(4.2), p=0.025; woO2:87.1(5.7) vs. 91.8(6.6), p=0.013). Presence vs. lack of intubation need was associated with significantly increased likelihood of saturation (wO2:93.1(5.3) vs. 95.9(3.8), p=0.013; woO2:87.6(8.3) vs. 92.3(5.9), p=0.007). Hospital discharge vs. ICU stay was associated with significantly higher ETCO2 values (wO2:27.9 (4.6) vs. 18.6(8.4), p=0.040; woO2: 30.1(4.9) vs. 23.8(6.9), p=0.040) Conclusion: Our findings revealed the association of decreased ETCO2 (w/wo O2) values with a lower likelihood of hospital discharge and increased likelihood of ICU transfer. Low oxygen saturation levels related the increased risk of both intubation need and mortality in hospitalized COVID-19 patients.

Keywords

Supporting Institution

yok

Project Number

yok

References

  1. Perlman S. Another decade, another coronavirus. N Engl J Med 2020; 382: 760-2.
  2. Zhang T, Wu Q, Zhang Z. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 outbreak. Curr Biol 2020; 30: 1578.
  3. Sun S, Cai X, Wang H, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta 2020; 507: 174-80.
  4. Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19 – A systematic review. Life Sci 2020; 254: 117788.
  5. Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med 2020; 201: 1299-300.
  6. Liu X, Liu X, Xu Y, et al. Ventilatory ratio in hypercapnic mechanically ventilated patients with COVID-19-associated acute respiratory distress syndrome. Am J Respir Crit Care Med 2020; 201: 1297-9.
  7. Pan C, Chen L, Lu C. Lung recruitability in COVID-19-associated acute respiratory distress syndrome: a single-center observational study. Am J Respir Crit Care Med 2020; 201: 1294-7.
  8. Henderson WR, Chen L, Amato MBP, Brochard LJ. Fifty years of research in ARDS. Respiratory mechanics in acute respiratory distress syndrome. Am J Respir Crit Care Med 2017; 196: 822-33.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

December 26, 2022

Submission Date

August 23, 2022

Acceptance Date

October 3, 2022

Published in Issue

Year 2022 Volume: 3 Number: 4

APA
Akyol, P. Y., Acar, H., Karaali, R., Bora, E. S., & Topal, F. (2022). The utility of ETCO2 value in predicting the progress of the disease and mortality risk in hospitalized patients with COVID-19 pneumonia. Journal of Medicine and Palliative Care, 3(4), 292-299. https://doi.org/10.47582/jompac.1166053
AMA
1.Akyol PY, Acar H, Karaali R, Bora ES, Topal F. The utility of ETCO2 value in predicting the progress of the disease and mortality risk in hospitalized patients with COVID-19 pneumonia. J Med Palliat Care / JOMPAC / jompac. 2022;3(4):292-299. doi:10.47582/jompac.1166053
Chicago
Akyol, Pınar Yeşim, Hüseyin Acar, Rezan Karaali, Ejder Saylav Bora, and Fatih Topal. 2022. “The Utility of ETCO2 Value in Predicting the Progress of the Disease and Mortality Risk in Hospitalized Patients With COVID-19 Pneumonia”. Journal of Medicine and Palliative Care 3 (4): 292-99. https://doi.org/10.47582/jompac.1166053.
EndNote
Akyol PY, Acar H, Karaali R, Bora ES, Topal F (December 1, 2022) The utility of ETCO2 value in predicting the progress of the disease and mortality risk in hospitalized patients with COVID-19 pneumonia. Journal of Medicine and Palliative Care 3 4 292–299.
IEEE
[1]P. Y. Akyol, H. Acar, R. Karaali, E. S. Bora, and F. Topal, “The utility of ETCO2 value in predicting the progress of the disease and mortality risk in hospitalized patients with COVID-19 pneumonia”, J Med Palliat Care / JOMPAC / jompac, vol. 3, no. 4, pp. 292–299, Dec. 2022, doi: 10.47582/jompac.1166053.
ISNAD
Akyol, Pınar Yeşim - Acar, Hüseyin - Karaali, Rezan - Bora, Ejder Saylav - Topal, Fatih. “The Utility of ETCO2 Value in Predicting the Progress of the Disease and Mortality Risk in Hospitalized Patients With COVID-19 Pneumonia”. Journal of Medicine and Palliative Care 3/4 (December 1, 2022): 292-299. https://doi.org/10.47582/jompac.1166053.
JAMA
1.Akyol PY, Acar H, Karaali R, Bora ES, Topal F. The utility of ETCO2 value in predicting the progress of the disease and mortality risk in hospitalized patients with COVID-19 pneumonia. J Med Palliat Care / JOMPAC / jompac. 2022;3:292–299.
MLA
Akyol, Pınar Yeşim, et al. “The Utility of ETCO2 Value in Predicting the Progress of the Disease and Mortality Risk in Hospitalized Patients With COVID-19 Pneumonia”. Journal of Medicine and Palliative Care, vol. 3, no. 4, Dec. 2022, pp. 292-9, doi:10.47582/jompac.1166053.
Vancouver
1.Pınar Yeşim Akyol, Hüseyin Acar, Rezan Karaali, Ejder Saylav Bora, Fatih Topal. The utility of ETCO2 value in predicting the progress of the disease and mortality risk in hospitalized patients with COVID-19 pneumonia. J Med Palliat Care / JOMPAC / jompac. 2022 Dec. 1;3(4):292-9. doi:10.47582/jompac.1166053

TR DİZİN ULAKBİM and International Indexes (1d)

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
 


 

download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiVHJfSW5kZXhfbG9nby5wbmciLCJwYXRoIjoiN2EzMC84NTVhL2UyMWMvNjlkZjRkZmVhNTUyNTYuNzg3NjU2ODgucG5nIiwiZXhwIjoxNzc2MjQ1Nzc0LCJub25jZSI6IjU0MDZkMWE2NmE1Y2QwZTJjNGYyNDA1OTM2MTE0YWIxIn0.Tt-WScFXTj5r2jji5eDMFApNzujLMjMPl8ivXRbozSI



f9ab67f.png
asos-index.png


 


download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiQ3Jvc3NyZWYuanBnIiwicGF0aCI6IjAzMzEvMTdkZi8yN2ZkLzY5ZGY0ZThhMDZkMjg0LjQxMjAyNDg5LmpwZyIsImV4cCI6MTc3NjI0NTkxNCwibm9uY2UiOiI2NjM1Yjc5MWFiY2I1MDQ0NjkzMTAxMDhjY2Y2NzRlMCJ9.5jDQBEY-KErkDK1QjDmv9ichOkNIn5CWYibe1Wz1644
icmje_1_orig.png
 
cc.logo.large.png
 
ncbi.png
 
google-scholar.pngpn6krf5.jpg
 


 

Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.

EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation. 

 

Journal articles are evaluated as "Double-Blind Peer Review"